Tel. 0049 (0) 6131-392-9292
Fax : 0049 (0) 6131-392-9293
To order send us an E-Mail : info@heparanase.de
|
|
Galantos HEParanase Assay:
References
- Patent pending
- McKenzie EA: Heparanase: a target for drug discovery in cancer
and inflammation. Br J Pharmacol 151:1-14, 2007
- Parish CR, Freeman C, Hulett MD: Heparanase: a key enzyme
involved in cell invasion. Biochim Biophys Acta 1471:99-108,
2001
- Rops AL, van der Vlag J, Lensen JF, et al.: Heparan sulfate
proteoglycans in glomerular inflammation. Kidney Int 65:768-
785, 2004
- Schoppmeyer K, Kronberg J, Tannapfel A, et al.: Predictive value
of heparanase expression in the palliative therapy of
pancreatic cancer. Pancreatology 5:570-575, 2005
- Takaoka M, Naomoto Y, Ohkawa T, et al.: Heparanase
expression correlates with invasion and poor prognosis in
gastric cancers. Lab Invest 83:613-622, 2003
- van den Hoven MJ, Rops AL, Vlodavsky I, et al.: Heparanase in
glomerular diseases. Kidney Int 72:543-548, 2007
- Vlodavsky I, Friedmann Y, Elkin M, et al.: Mammalian
heparanase: gene cloning, expression and function in tumor
progression and metastasis. Nat Med 5:793-802, 1999
- Vlodavsky I, Goldshmidt O, Zcharia E, et al.: Mammalian
heparanase: involvement in cancer metastasis, angiogenesis
and normal development. Semin Cancer Biol 12:121-129, 2002
- Zcharia E, Zilka R, Yaar A, et al.: Heparanase accelerates wound
angiogenesis and wound healing in mouse and rat models.
+Faseb J 19:211-221, 2005
|
 
|
|